RACIAL DIFFERENCES IN THE IMPACT OF HYDROXYCHLOROQUINE ON IMMUNOLOGIC MARKERS IN SLE PATIENTS

被引:0
|
作者
Magder, L. [1 ]
Goldman, D. [2 ]
Petri, M. A. [2 ]
机构
[1] Univ Maryland, Sch Med, Epidemiol & Publ Hlth, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Clin & Mol Rheumatol, Baltimore, MD 21205 USA
关键词
D O I
10.1136/annrheumdis-2020-eular.5059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0167
引用
收藏
页码:1020 / 1021
页数:2
相关论文
共 50 条
  • [1] Impact of Hydroxychloroquine Treatment on Immunologic Markers in SLE Depends on Ethnicity
    Magder, Laurence
    Goldman, Daniel
    Petri, Michelle
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [2] Racial Differences in Medication Beliefs Among SLE Patients
    Anderson, D. Ryan
    Eudy, Amanda
    Clowse, Megan
    Sadun, Rebecca
    Rogers, Jennifer
    Criscione-Schreiber, Lisa
    Doss, Jayanth
    Volis, Corrine
    Coles, Theresa
    Sun, Kai
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1220 - 1221
  • [3] Pericentral Retinopathy and Racial Differences in Hydroxychloroquine Toxicity
    Melles, Ronald B.
    Marmor, Michael F.
    [J]. OPHTHALMOLOGY, 2015, 122 (01) : 110 - 116
  • [4] SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment
    Joob, Beuy
    Wiwanitkit, Viroj
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (06)
  • [5] Hydroxychloroquine and QTc Prolongation in a Cohort of SLE Patients
    Haj-Ali, Mayce
    Belmont, H. Michael
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [6] Racial Differences in Chronic Glucocorticoid Use in Patients with SLE: A Cross Sectional Study
    Sullivan, James
    Littlejohn, Emily
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2611 - 2614
  • [7] Racial Differences in Medication Beliefs and Barriers to Taking Medications Among Patients with SLE
    Cisneros, Emilio Guzman
    Herndon, Shannon
    Coles, Theresa
    Voils, Corrine
    Clowse, Megan
    Sadun, Rebecca
    Rogers, Jennifer
    Criscione-Schreiber, Lisa
    Doss, Jayanth
    Eudy, Amanda
    Sun, Kai
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 212 - 215
  • [8] The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients
    Toubi, E
    Rosner, I
    Rozenbaum, M
    Kessel, A
    Golan, TD
    [J]. LUPUS, 2000, 9 (02) : 92 - 95
  • [9] DISCRIMINATION OF SYSTEMIC LUPUS (SLE) PATIENTS WITH CLINICAL RESPONSE TO OBEXELIMAB (XMAB®5871) BASED ON A PATTERN OF IMMUNOLOGIC MARKERS
    Merrill, J. T.
    Guthridge, J.
    Zack, D.
    Foster, P.
    Burington, B.
    Tran, L.
    Smith, M.
    James, J. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1031 - 1032
  • [10] RACIAL-DIFFERENCES IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    PETRI, M
    CONROY, M
    CAFFENTZIS, E
    GOLDMAN, D
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S274 - S274